✦ LIBER ✦

P456 SYSTEMS BIOLOGY ANALYSIS OF PROBIOTIC LACTOBACILLUS GG IN CIRRHOTIC PATIENTS WITH MINIMAL HEPATIC ENCEPHALOPATHY: A RANDOMIZED DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

✍ Scribed by Bajaj, J.S.; Heuman, D.; Hylemon, P.; Sanyal, A.; Sterling, R.; Stravitz, R.; Puri, P.; Sikaroodi, M.; Thacker, L.R.; Wade, J.; Gillevet, P.M.

Book ID: 122180219
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 64 KB
Volume: 60
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(14)60618-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomised clinical trial: rifaximin imp

Randomised clinical trial: rifaximin improves health-related quality of life in cirrhotic patients with hepatic encephalopathy – a double-blind placebo-controlled study

✍ A. Sanyal; Z. M. Younossi; N. M. Bass; K. D. Mullen; F. Poordad; R. S. Brown; R. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 471 KB

Rifaximin Improves Cognitive Functions a

Rifaximin Improves Cognitive Functions and Health-Related Quality of Life in Patients With Minimal Hepatic Encephalopathy: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial (The RIME Trial)

✍ Sidhu, Sandeep; Goyal, Omesh; Mishra, Bholeshwar P.; Sood, Ajit; Chhina, Rajoo S 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 111 KB

P588 A randomized double blind placebo c

P588 A randomized double blind placebo controlled trial to assess the efficacy of a probiotic preparation as maintenance therapy in patients with ulcerative colitis

✍ Suzuki, Y.; Yamada, A.; Yoshimatsu, Y.; Takeuchi, K. 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 49 KB

MMX Multi Matrix System® mesalazine for

MMX Multi Matrix System® mesalazine for the induction of remission in patients with mild-to-moderate ulcerative colitis: a combined analysis of two randomized, double-blind, placebo-controlled trials

✍ W. J. SANDBORN; M. A. KAMM; G. R. LICHTENSTEIN; A. LYNE; T. BUTLER; R. E. JOSEPH 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 566 KB

Su1049 Faldaprevir Plus Pegylated Interf

Su1049 Faldaprevir Plus Pegylated Interferon Alfa-2A and Ribavirin in Treatment-Naïve Patients With Chronic Hepatitis C Genotype-1 Infection: A Pooled Analysis of Two Randomized, Double-Blind Placebo-Controlled Phase III Trials (Startverso1&2)

✍ Jensen, Donald M.; Foster, Graham; Ferenci, Peter; Cooper, Curtis; Dieterich, Do 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 292 KB